Physician profile
Eugeniu Muntean
NPI 1407017882
$1,403.25
in general payments reported to CMS, 2019-2025
16 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $128 · 2021: $256 · 2022: $83.98 · 2023: $141 · 2024: $272 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $324.86 | 2019-2025 | Vyepti |
| Amgen INC. | $202.80 | 2019-2025 | Uplizna, Aimovig |
| Abbvie INC. | $200.97 | 2021-2025 | |
| Lilly USA, LLC | $177.52 | 2019-2024 | Emgality, Reyvow |
| Allergan, INC. | $90.64 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $82.63 | 2023-2025 | Ajovy, Austedo Xr |
| Upsher-Smith Laboratories LLC | $70.89 | 2020-2022 | |
| Amneal Pharmaceuticals LLC | $57.48 | 2019-2021 | |
| Pfizer INC. | $39.20 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $33.86 | 2019-2021 | |
| Ucb, INC. | $30.89 | 2024 | Zilbrysq |
| Alnylam Pharmaceuticals INC. | $26.70 | 2023 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $21.68 | 2025 | Wainua |
| Biohaven Pharmaceutical Holding Company LTD. | $16.64 | 2022 | |
| Boston Scientific Corporation | $15.20 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $11.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugeniu Muntean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.